Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 17, 2026ACS Infectious Diseases

A Modular Biomimetic Nanovaccine for TBEV: Orchestrating Cascade Immunoprotection via Programmed Dendritic Cell Targeting and Antigen–Adjuvant Co-delivery

View Full Paper
Ask AI
Bookmark
Share

Authors

NLNAMES. Yuancheng LiKMKunrong MiaoMZMengyao Zhang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2026) studied this question.

synapsesocial.com/papers/6aabb7e75f706d05830e7457https://doi.org/10.1021/acsinfecdis.6c00544
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Influence of adjuvant type and route of administration on the immunogenicity of Leishmania-derived tick-borne encephalitis virus-like particles – A recombinant vaccine candidate2024 · 2 citations
  2. 2Development of an mRNA Vaccine for Tick-Borne Encephalitis: Selection of a Prototype Virus Strain2026
  3. 3A replication-defective tick-borne encephalitis virus generated by NS1 trans-complementation confers robust protective efficacy2026
  4. 4The importance of the role of T-cell immunity in the development of modern tick-borne encephalitis vaccines2024 · 1 citations
  5. 5How Does Inter-Epitope Spacer Variation Within Artificial Immunogens Based on T-Cell Epitopes of Tick-Borne Encephalitis Virus Affect Immunogenicity?2026